Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Center for International Blood and Marrow Transplant Research
Novartis
National Institutes of Health Clinical Center (CC)
Takeda
Center for International Blood and Marrow Transplant Research
Crossbow Therapeutics, Inc.
Masonic Cancer Center, University of Minnesota
Novartis
University of California, Irvine
Hackensack Meridian Health
Massachusetts General Hospital
Novartis
Novartis
Groupe Francophone des Myelodysplasies
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Gamida Cell ltd
Ossium Health, Inc.
Dartmouth-Hitchcock Medical Center
Children's Hospital Medical Center, Cincinnati
M.D. Anderson Cancer Center
Center for International Blood and Marrow Transplant Research
Novartis
Center for International Blood and Marrow Transplant Research
Alliance for Clinical Trials in Oncology
Peking University People's Hospital
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute
Augusta University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
MacroGenics
Terns, Inc.
Enliven Therapeutics
Masonic Cancer Center, University of Minnesota
Novartis
University of Chicago
Ohio State University Comprehensive Cancer Center
Stanford University
Baylor College of Medicine
Stanford University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Rigshospitalet, Denmark
Novartis